Pharmacogenetics: pharmacogenie or pharmacogenerality in future drug discovery and development? Anthony D. Dayan Commentary 24 August 2012 Pages: 54 - 56
Pharmacogenetics Working Party: introduction Stephen T. HolgateMartin W. Lunnon Report 24 August 2012 Pages: 63 - 65
Regulatory aspects of integration of pharmacogenetics into drug development Rashmi R. Shah Report 24 August 2012 Pages: 67 - 69
Drug disposition: to phenotype or genotype Maurice DickinsGeoff Tucker Report 24 August 2012 Pages: 70 - 73
Pharmacogenetics: focus on pharmacodynamics Klaus LindpaintnerElizabeth FootIan Hall Report 24 August 2012 Pages: 74 - 82
The pharmacogenetic basis of adverse drug reactions John Caldwell Report 24 August 2012 Pages: 83 - 84
Technology: methodologies in genomics and proteomics Jon TerrettJohn MorrisonChris Moyses Report 24 August 2012 Pages: 85 - 88
Impact of pharmacogenetics on health care and health economics Elizabeth FootFlorian BieberThomas Weihrauch Report 24 August 2012 Pages: 95 - 100
News from members’ associations Herman LahonMarc PierredonChristopher Allen IFAPP News 24 August 2012 Pages: 102 - 106
Meeting report: Managing quality in clinical research and development Robert N. Smith IFAPP News 24 August 2012 Pages: 106 - 110
Executive summary: IFAPP Working Party: Education in Pharmaceutical Medicine IFAPP News 24 August 2012 Pages: 111 - 111